The chair of the Nonclinical Biostatistics Communications team is Kristi Griffiths (Eli Lilly).
We list our notable events and communications on this site.
Events
The Nonclinical Biostatistics Working Group (NCBWG) held its biennial Nonclinical Biostatistics Conference virtually in June, 2021. We look forward to your participation in 2023!
Communications
| Fall 2021 |
Article:
A Brief and Biased history of the Nonclinical Biostatistics Leaders’ Forum and the Evolution of the Nonclinical Biostatistics Conference, Stan Altan (Janssen) and Don Bennett (Pfizer) in the Biopharmaceutical Report (Fall, 2021)
|
| Summer 2021 |
Article:
Bayesian Methods in CMC-Has the Time Come For a Regulatory Guidance?, co-authored by Paul Faya (Eli Lilly) Donald Berry (Berry Consultants) in the Biopharmaceutical Report (Summer, 2021)
|
| Spring 2021 |
Article:
WHY IS NONCLINICAL STATISTICS NOT CALLED BY WHAT IT IS?, co-authored by Stan Altan (Janssen) and John Kolassa (Rutgers University) in the Biopharmaceutical Report (Spring, 2021) |
| Winter 2021 |
Article:
REPORT ON THE NON-CLINICAL BIOSTATISTICS SCIENTIFIC WORKING GROUP ON P-VALUES, co-authored by Stan Altan (Janssen), John Kolassa (Rutgers University), Steve Novick (AstraZeneca) in the Biopharmaceutical Report (Winter, 2021) |